Caseware UK (AP4) 2024.0.164 2024.0.164 2024-07-312024-07-312025-05-02The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false2023-07-19No description of principal activity10truetruefalse SC776292 2023-07-18 SC776292 2023-07-19 2024-07-31 SC776292 2022-07-19 2023-07-18 SC776292 2024-07-31 SC776292 c:Director1 2023-07-19 2024-07-31 SC776292 d:CurrentFinancialInstruments 2024-07-31 SC776292 d:CurrentFinancialInstruments d:WithinOneYear 2024-07-31 SC776292 d:ShareCapital 2024-07-31 SC776292 d:RetainedEarningsAccumulatedLosses 2024-07-31 SC776292 c:OrdinaryShareClass1 2023-07-19 2024-07-31 SC776292 c:OrdinaryShareClass1 2024-07-31 SC776292 c:FRS102 2023-07-19 2024-07-31 SC776292 c:AuditExempt-NoAccountantsReport 2023-07-19 2024-07-31 SC776292 c:FullAccounts 2023-07-19 2024-07-31 SC776292 c:PrivateLimitedCompanyLtd 2023-07-19 2024-07-31 SC776292 e:PoundSterling 2023-07-19 2024-07-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: SC776292









MEDICAL MACABRE LTD







UNAUDITED

FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 JULY 2024

 
MEDICAL MACABRE LTD
REGISTERED NUMBER: SC776292

BALANCE SHEET
AS AT 31 JULY 2024

2024
Note
£

  

Current assets
  

Stocks
 4 
156,156

Debtors: amounts falling due within one year
 5 
10,268

Cash at bank and in hand
 6 
85,209

  
251,633

Creditors: amounts falling due within one year
 7 
(248,632)

Net current assets
  
 
 
3,001

Total assets less current liabilities
  
3,001

  

Net assets
  
3,001


Capital and reserves
  

Called up share capital 
 8 
1

Profit and loss account
  
3,000

  
3,001


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.
 
Page 1

 
MEDICAL MACABRE LTD
REGISTERED NUMBER: SC776292
    
BALANCE SHEET (CONTINUED)
AS AT 31 JULY 2024


The financial statements were approved and authorised for issue by the board and were signed on its behalf on2 May 2025




L Brewster
Director

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
MEDICAL MACABRE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2024

1.


General information

Medical Macabre Ltd is a private company limited by shares and registered in England & Wales. The
address of its registered office is 106 Harriet Street, Kirkcaldy, Scotland, KY1 2AG.
The company was incorporated 19 July 2023 and began trading on this date.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue comprises donations received.
Donations are recognised in the Statement of Income and Retained Earnings when income is probable and can be measured with sufficient reliability.

 
2.3

Stocks

Stocks comprise film production costs, which are recorded as a current asset. Film production costs
are amortised to the Statement of Income and Retained Earnings over the period in which rights to
the relevant production are being exploited by the Company.

 
2.4

Debtors

Short term debtors are measured at the transaction price, less any impairment.

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty
on notice of not more than 24 hours.

 
2.6

Creditors

Short term creditors are measured at the transaction price, less any impairment.

 
2.7

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of
financial assets and liabilities like trade and other debtors and creditors and loans to related parties.



3.


Employees

The average monthly number of employees, including directors, during the period was 1.

Page 3

 
MEDICAL MACABRE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2024

4.


Stocks

2024
£

Film production costs
156,156

156,156



5.


Debtors

2024
£


Other debtors
10,268

10,268



6.


Cash and cash equivalents

2024
£

Cash at bank and in hand
85,209

85,209



7.


Creditors: Amounts falling due within one year

2024
£

Other creditors
70,000

Accruals and deferred income
178,632

248,632


Page 4

 
MEDICAL MACABRE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2024

8.


Share capital

2024
£
Allotted, called up and fully paid


1 Ordinary share of £1.00
1


On incorporation the company issued 1 ordinary share of £1 each at par for a cash consideration.


9.


Related party transactions

During the period, film production services of £26,667 and advances totalling £10,000 were received from Hex Media Ltd, a company in which L Brewster is also a director. All transactions were carried out at arms length. At the reporting date £70,000 was due to Hex Media Ltd. The loan is repayable on demand and not interest bearing.
During the period, film production services totalling £30,000 were received from Pathhead Halls Ltd, a company in which L Brewster is also a director. All transactions were carried out at arms length. At the reporting date £Nil was due to Pathhead Halls Ltd.
During the period, film production services totalling £10,000 were received from Church Films Post Production Ltd, a company in which L Brewster is also a director. All transactions were carried out at arms length. At the reporting date £Nil was due to Church Films Post Production Ltd.


10.


Controlling party

During the period, the company was under the control of L Brewster by virtue of his shareholding.

 
Page 5